DSIP 5mg
In stock
DSIP 5mg is supplied as a research vial of delta-sleep-inducing peptide. This nonapeptide has been investigated through sleep recordings and human sleep studies, offering a focused research context around sleep architecture and regulation.
YOU MAY ALSO LIKE
DSIP and sleep architecture
DSIP 5mg is delta-sleep-inducing peptide, a nine-amino-acid compound with a research history centred on sleep physiology. The “delta” name connects it with slow-wave activity, one of the features measured when studying the structure of sleep.
From sleep recordings to human observations
Early human work included a double-blind crossover study in six healthy volunteers. Researchers examined physiological recordings and sleep behaviour to investigate whether a peptide signal could influence the organisation of sleep.
Later work in people with chronic insomnia assessed sleep efficiency, the time taken to fall asleep, perceived sleep quality and daytime tiredness. Looking at these outcomes together is valuable because objective recordings and a person's experience of sleep measure different aspects of the same process.
Interpreting the research signals
A double-blind study in 16 patients reported changes in some objective sleep measures, but the effects were weak and subjective sleep quality did not improve. The investigators regarded the clinical benefit as limited. The findings support continued interest in sleep-regulatory mechanisms while leaving reliable insomnia efficacy unresolved.
DSIP therefore has a specific place in peptide and sleep research, with the experimental endpoints more informative than its name alone.
Also known as / branded as
- Delta-sleep-inducing peptide
- Delta sleep-inducing peptide
| Dynamic Performance Range | Dynamic Performance: Peptides |
|---|
